Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-17

Clinical Trial Update: Elimisha HPV (Human Papillomavirus) [NA]

View source ↗

Summary

The clinical trial of Elimisha HPV sponsored by Duke University has completed, studying cervical cancer and human papillomavirus infection. The update provides …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elimisha HPV

Snippet

Sponsor: Duke University | Conditions: Cervical Cancer, HPV | NA | Status: COMPLETED